3Jankel, CA; Speedie, SM. Detecting drug interactions: a review of the literature[J]. DICP, 1990, 24(10): 982.
4Prince, BS; Goetz, CM; Rihn, T L; et al. Drug-related emergency department visits and hospital admissions [J].Am J Hosp Pharm, 1992, 49(7): 1696.
5Zhan C, Correa-de-Araujo R. Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drugdisease combinations[J].J Am Geriatr Soc. 2005, 53 (2):262.
6Courtman B J; Stallings, SB. Characterization of drug-related problems in elderly patients on admission to a medical ward[J]. Can J Hosp Pharm, 1995, 48(3): 161.
7Monahan BP, Ferguson CL, Killeavy ES, et al. Torsades de pointes occurring in association with terfenadine use [J].JAMA, 1990, 264(21):2788.
9Watabe T. Strategic proposals for predicting drug-drug interactions during new drug development: based on sixteen deaths caused by interactions of the new antiviral sorivu dine with 5-fluorouracil prodrugs[J]. J Toxicol Sci, 1996,21(5):299.
10Okuda H, Nishiyama T, Ogura K, et al.Lethal drug interactions of sorivudine, a new antiviml drug, with oral 5-fluorouracil prodrugs[J]. Drug Metab Dispos, 1997, 25(5):270.
